Position in IVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,117,352
+$1,316,328 QoQ
Shares Held
1,462,586
0.0% QoQ
Ownership
0.619%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NEA Management Company, LLC holds $1,651,836,644 across 23 Biotechnology names. IVA ranks #16 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
3,045,262 | $349,656,982 | |
| 2 | CELC |
Celcuity Inc.
|
2,285,561 | $260,873,932 | |
| 3 | SGP |
SpyGlass Pharma, Inc.
|
7,392,301 | $191,534,518 | |
| 4 | TRVI |
Trevi Therapeutics, Inc.
|
13,222,228 | $157,741,180 | |
| 5 | SVRA |
Savara Inc
|
24,471,264 | $133,613,101 | |
| 6 | GLUE |
Monte Rosa Therapeutics, Inc.
|
7,692,298 | $126,538,302 | |
| 7 | MBX |
MBX Biosciences, Inc.
|
3,614,486 | $107,892,407 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
4,023,219 | $78,653,931 |
All Filings in IVA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,117,352 | 1,462,586 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $6,801,024 | 1,462,586 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $8,468,372 | 1,462,586 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,665,649 | 1,462,586 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,300,002 | 1,462,586 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,129,934 | 1,462,586 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,727,722 | 1,462,586 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,373,132 | 1,462,586 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,294,561 | 1,462,586 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,605,038 | 1,462,586 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,142,861 | 1,462,586 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,908,847 | 1,462,586 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,323,813 | 1,462,586 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,523,133 | 1,462,586 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $21,918,424 | 5,572,953 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,598,643 | 5,572,953 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,805,180 | 1,298,700 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $17,740,242 | 1,298,700 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $18,389,592 | 1,298,700 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $14,203,115 | 1,041,666 | Shares | Defined | 2021-08-02 | |
| 2021-03-31 | $15,312,490 | 1,041,666 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $15,104,157 | 1,041,666 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $12,312,492 | 1,041,666 | Shares | Defined | 2020-11-06 | |
| No filing history on record for this holder in this stock. | ||||||